Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme
- 1 January 2004
- journal article
- research article
- Vol. 25 (3) , 55-67
Abstract
Australia has had a government subsidized universal system of pharmaceutical provision for 50 years. The Pharmaceutical Benefits Scheme (PBS) consumes around 14 percent of total government health care expenditures and has grown substantially in both range of drugs covered, and expenditure since it was first introduced in 1950. It incorporates patient copayments (with differentials for the general population compared with concessional beneficiaries). Prior to listing a drug on the PBS it is subject to a rigorous cost-effectiveness analysis.Keywords
This publication has 25 references indexed in Scilit:
- The drug bargaining game: pharmaceutical regulation in AustraliaJournal of Health Economics, 2004
- Generic drugs: international trends and policy developments in Australia.Australian Health Review, 2004
- Dilemmas In Regulation Of The Market For PharmaceuticalsHealth Affairs, 2003
- Pharmaceutical advertisement claims in Australian medical publicationsThe Medical Journal of Australia, 2002
- Selling sickness: the pharmaceutical industry and disease mongering * Commentary: Medicalisation of risk factorsBMJ, 2002
- Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in OncologyJAMA, 1999
- Pharmaceutical company promotion: striking a balanceAustralian and New Zealand Journal of Medicine, 1998
- Economic evaluation of pharmaceuticals: what are reasonable standards for clinical evidence-the Australian experiencePublished by Wiley ,1997
- Trials of providing costing information to general practitioners: a systematic reviewThe Medical Journal of Australia, 1997
- Promoting and advertising therapeutic goods. Trade Practices Commission report on self-regulation.1992